Zobrazeno 1 - 10 of 169 pro vyhledávání: '"Sb, Sirima"'
2
Akademický článek
Force of Infection (FOI) and Multiplicity of Infection (MOI) in Plasmodium falciparum Infected Children Aged 1.5-12 Years Living in the Malaria Endemic Area of Banfora, Burkina Faso.
Autor: Badoum ES; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Kouraogo L; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Ouattara D; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Nebie I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso.
Publikováno v: Pathogens (Basel, Switzerland) [Pathogens] 2024 Oct 10; Vol. 13 (10). Date of Electronic Publication: 2024 Oct 10.
Zobrazit plný text záznamu
3
Akademický článek
Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol.
Autor: Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), 06 BP 10248, Ouagadougou 06, Burkina Faso. a.ouedraogo@gras.bf., Pouplin JNN; ReMeD, 21bis Avenue du Commandant de L'Herminier, Saint-Nazaire, 44 600, France., Mukaka M; Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kaendiao T; Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand., Ruecker A; Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Millet P; ReMeD, 21bis Avenue du Commandant de L'Herminier, Saint-Nazaire, 44 600, France., Vallet T; ClinSearch, 110 Avenue Pierre Brossolette, Malakoff, 92240, France., Ruiz F; ClinSearch, 110 Avenue Pierre Brossolette, Malakoff, 92240, France., Sirima SB; Groupe de Recherche Action en Santé (GRAS), 06 BP 10248, Ouagadougou 06, Burkina Faso., Taylor WR; Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Publikováno v: Trials [Trials] 2024 Sep 03; Vol. 25 (1), pp. 583. Date of Electronic Publication: 2024 Sep 03.
Zobrazit plný text záznamu
4
Akademický článek
Effect of weekly fever-screening and treatment and monthly RDT testing and treatment on the infectious reservoir of malaria parasites in Burkina Faso: a cluster-randomised trial.
Autor: Collins KA; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Ouedraogo A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Guelbeogo WM; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Soulama I; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Ouattara MS; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Sombie S; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Ouedraogo N; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Coulibaly AS; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Nombre A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Lanke K; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Ramjith J; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Awandu SS; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Serme SS; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Henry N; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Stone W; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Ouedraogo IN; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Diarra A; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Holden TM; Department of Preventive Medicine and Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Sirima SB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Bradley J; International Statistics and Epidemiology Group, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Soremekun S; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Selvaraj P; Institute for Disease Modeling, Bellevue, WA, USA., Gerardin J; Department of Preventive Medicine and Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Institute for Disease Modeling, Bellevue, WA, USA., Drakeley C; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Bousema T; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands. Electronic address: teun.bousema@radboudumc.nl., Tiono AB; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Sep; Vol. 5 (9), pp. 100891. Date of Electronic Publication: 2024 Jul 25.
Zobrazit plný text záznamu
5
Akademický článek
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
Autor: Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Plieskatt JL; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Soulama BI; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Naghizadeh M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Barry A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Yaro JBB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ezinmegnon S; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Henry N; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ofori EA; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Adu B; Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana., Singh SK; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Konkobo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Lövgren Bengtsson K; Novavax AB, Uppsala, Sweden., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Carnrot C; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Tienta M; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ouedraogo IN; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sagara I; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Theisen M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01.
Zobrazit plný text záznamu
6
Akademický článek
Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial.
Autor: Moreno M; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Barry A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Gmeiner M; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Yaro JB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sermé SS; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Byrne I; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Ramjith J; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Ouedraogo A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Soulama I; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Grignard L; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Soremekun S; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Koele S; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Ter Heine R; Pharmacy, Radboudumc, Nijmegen, The Netherlands., Ouedraogo AZ; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sawadogo J; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sanogo E; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Ouedraogo IN; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Hien D; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sirima SB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Bradley J; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Bousema T; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Drakeley C; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Tiono AB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso a.tiono@gras.bf.
Publikováno v: BMJ open [BMJ Open] 2024 Mar 12; Vol. 14 (3), pp. e081682. Date of Electronic Publication: 2024 Mar 12.
Zobrazit plný text záznamu
7
Akademický článek
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
Autor: Puri A; Hammersmith Medicines Research Limited, Cumberland Avenue, London NW10 7EW, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), and NIHR Oxford Biomedical Research Centre, Churchill Hospital, Old Road, Headington, Oxford OX3 7LE, UK., Schmidt-Mutter C; Inserm CIC 1434, CHU Strasbourg, 1 Place de l'Hôpital, 67091 Strasbourg, France., Lainé F; Inserm CIC 1414, CHU Rennes, Rue Henri Le Guillou, 35033 Rennes, France., PrayGod G; Mwanza Research Center, National Institute for Medical Research, Isamilo Road, Mwanza P.O. Box 1462, Tanzania., Kibuuka H; Makerere University Walter Reed Project, Plot 42 Nakasero Road, Kampala P.O. Box 16524, Uganda., Barry H; Centre MURAZ, 2054 Avenue Mamadou Konaté, Bobo Dioulasso 01 BP 390, Burkina Faso., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, 69364 Lyon, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, CHU Henri Mondor 1 rue Gustave Eiffel, 94000 Créteil, France., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Kamala B; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania., Manno D; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK., Watson-Jones D; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK., Gaddah A; Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium., Keshinro B; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Luhn K; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Robinson C; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Douoguih M; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands.
Publikováno v: Vaccines [Vaccines (Basel)] 2024 Feb 17; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 17.
Zobrazit plný text záznamu
8
Akademický článek
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria.
Autor: Nebie I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 10248, Burkina Faso., Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Osaka, Japan., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 10248, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 10248, Burkina Faso., Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 10248, Burkina Faso., D'Alessio F; European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Voßstraße 2, 69115 Heidelberg, Germany., Houard S; European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Voßstraße 2, 69115 Heidelberg, Germany., Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 10248, Burkina Faso., Cousens S; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK., Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Osaka, Japan., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 10248, Burkina Faso.
Publikováno v: Vaccines [Vaccines (Basel)] 2024 Feb 06; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 06.
Zobrazit plný text záznamu
9
Akademický článek
Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso.
Autor: Héma A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Sermé SS; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Sawadogo J; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Barry A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Ouédraogo AZ; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Nébié I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Houard S; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg Vossstrasse 2, Geb. 4040, 69115 Heidelberg, Germany., Chakraborty S; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso.
Publikováno v: Microorganisms [Microorganisms] 2023 Nov 19; Vol. 11 (11). Date of Electronic Publication: 2023 Nov 19.
Zobrazit plný text záznamu
10
Akademický článek
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Autor: Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Japan., Houard S; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Nebie I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sawadogo J; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Berges GD; Hôpital Protestant Schiphra, Ouagadougou, Burkina Faso., Soulama I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Hien D; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ouedraogo AZ; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Konaté AT; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Kouanda S; Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso., Myoui A; Medical Center for Translational Research, Osaka University Hospital, Suita, Japan., Ezoe S; Medical Center for Translational Research, Osaka University Hospital, Suita, Japan.; Department of Space Infection Control, Graduate School of Medicine, Division of Health Sciences, Osaka University, Osaka, Japan., Ishii KJ; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Suita, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Sato T; Research and Development Division, Nobelpharma Co., Ltd., Tokyo, Japan., D'Alessio F; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Leroy O; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Cousens S; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom., Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Japan., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Publikováno v: Frontiers in immunology [Front Immunol] 2023 Oct 16; Vol. 14, pp. 1267372. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje